➣ Original Article
➣ Asp Biomed Clin Case Rep, vol.2, no.1: 10-12, 2019
Selim E1*, Selim M2, Auf R3
1Director, Retinal Unit, Eye Surgery Consultant, London, United Kingdom
2Retinal Unit, Eye Surgery Consultant, London, United Kingdom
3Associate professor, Department of Health, Human Performance, and leisure (HHPL), College of Arts and Science (COAS),Howard University, Washington, DC 20059, USA
Corresponding Author: Emad Selim, MD, FRCOphth
Address: Retinal Unit, Eye Surgery Consultant, 85 Great Portland street, London, W1W 7LT, United Kingdom.
Received date: 19 March 2019; Accepted date: 30 March 2019; Published date: 05 April 2019
Abstract
Purpose/Aim of the study: Authors planned to study articles published in 2018 to find out the latest update on this rare condition.
Materials and Methods: Pubmed search was conducted with 2018 in focus as a year of publication including only articles on humans and in English language.
Results: out of 22 articles published in 2018, only 7 were found relevant on human subjects and in English language.
Conclusions: Newer treatment modalities were tried in 2018 as well as the old well approved modalities.
Citation: Selim E, Selim M, Auf R, “Coats’ Disease, The 2018 Brief”. Asp Biomed Clin Case Rep, vol.2, no.1: 10-12, 2019
Copyright © 2019 Selim E, Selim M, Auf R, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Key Words: Coats; Exudative; Retinal; Detachment; Photodynamic
